Oscient Pharmaceuticals Corporation

BrainStorm Cell Therapeutics Inc. is taking an unusual regulatory route to the US Food and Drug Administration advisory committee meeting it wanted for NurOwn, its stem cell therapy for amyotrophic l

ProTA has named Mesoblast Ltd. 's former vice president operations, Suzanne Lipe, CEO. Lipe has previous experience in executive management positions for drug development and commercial progra

Lupin, India's third largest drug firm by sales, reported a 38% jump in net sales to Rs24.65 billion ($463 million) for the third quarter ended 31 December 2012, buoyed by a strong showing in the US m

Lupin has introduced fenofibrate tablets 48mg and 145mg, generic versions of Abbott's TriCor, on the US market, in what’s seen as a ‘material’ launch for the Indian firm in the short term. The generic